Hyaluronic Acid Based Dermal Fillers Market to Reach USD 6.93 Billion by 2029; Revance Therapeutics, Inc. Attained U.S. FDA Permit to Surge Growth Prospect

The global hyaluronic acid based dermal fillers market size was valued at USD 3.89 billion in 2021. The market is projected to grow from USD 4.11 billion in 2022 to USD 6.93 billion by 2029, exhibiting a CAGR of 7.7% during the forecast period.

This information is provided by Fortune Business Insights, in its report, titled, “Hyaluronic Acid Based Dermal Fillers Market Size, Share & COVID-19 Impact Analysis, By Crosslinking Type (Monophasic and Biphasic), By Application (Scar Treatment, Wrinkle Correction Treatment, Lip Enhancement, Restoration of Volume/Fullness, and Others), By End-user (Specialty & Dermatology Clinics, Hospitals & Clinics, and Others), and Regional Forecast, 2022-2029.”

Hyaluronic acid based dermal fillers are also called as hyaluronan, a clear element that is naturally generated in the human body. There are two kinds of hyaluronic acid based dermal fillers accessible, involving biphasic and monophasic. The players functioning in the market are emphasizing on continual invention and upgrade of their product portfolio with novel and proficient product offerings for enhanced and precise aesthetic consequences for patients.

COVID-19 Pandemic Deaccelerated Market Growth in 2020 due to Closing of Dermatology Clinics 

The impact of COVID-19 led to lower demand for HA-based dermal fillers in 2020. This is accredited to the elimination in dermal filler surgeries and reduced admission rate for anti-aging treatment during the pandemic. The global market perceived a deterioration of -24.8% in 2020 in comparison with 8.3% in 2019.

The extensive commotion triggered by COVID-19 has substantially swayed the production of raw hyaluronic acid. The infliction of lockdown in possibly impacted areas resulted in a termination in the supply chain of dermal fillers, resulting in a drop in sales.

Galderma to Unveil Expansive New Clinical Record Across its Portfolio at IMCAS World Congress 2022

Galderma will offer a series of novel clinical information and evaluations throughout its portfolio during nine meetings and two conferences at the forthcoming International Master Course on Aging Science (IMCAS) World Congress 2022 in Paris dated June 3rd-5th, 2022.

Galderma unveiled medical data on its hyaluronic acid dermal filler series at the Aesthetic & Anti-Aging Medicine World Congress (AMWC). The corporation offered the data for Alluzience and Sculptra.

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/industry-reports/hyaluronic-acid-based-dermal-fillers-market-100951

Rising HA-based Dermal Fillers Procedures and Presentation of Novel Products to Thrive Market

Fillers are used to address scars, acne, and wrinkles, as well as cheek, chin, and lip enhancement. Therefore, this has resulted in a profound curiosity among patients across the globe for dermal filler-based procedures.

Aspects, such as repair discoloration, skin resilience, and skin cell regeneration, are linked with hyaluronic acid fillers and have augmented their acceptance in the market. Additionally, the upsurge in the number of hyaluronic acid dermal filler procedures in comparison with other nonsurgical procedures is predicted to spur the hyaluronic acid based dermal fillers market growth during the forecast period.

Competitive Landscape:

Important Business-related Announcements by Key Players to Influence Market Dynamics

Fundamental companies in the market often make crucial announcements regarding some business moves, which, in turn, affect the market either positively or negatively. Players acquire companies, launch new products, engage in partnership deals, sign contracts with government organizations, and so on.

Notable Industry Developments:

• December 2021: Revance Therapeutics, Inc. received the U.S. FDA sanction for RHA Redensity dermal filler for the treatment of perioral rhytids (lip lines).

List of Key Players Mentioned in the Report:

• Allergan Aesthetics (AbbVie Inc.) (U.S.)


• Revance Therapeutics, Inc. (U.S.)


• Merz Pharma (Germany)


• Galderma (Switzerland)


• Sinclair Pharma (U.K.)


• BIOPLUS CO., LTD. (South Korea)


• Bioxis Pharmaceuticals (France)


• DR. Korman (Israel)


• Prollenium Medical Technologies (Canada)


• Teoxane (Switzerland)

Further Report Findings

North America held the largest hyaluronic acid based dermal fillers market share and was valued at USD 1.77 billion in 2021. It is projected to expand at a substantial CAGR during the forecast period. The growth is due to the rapid adoption of monophasic, well-established healthcare infrastructure, and extensive R&D initiatives by leading players.

Based on crosslinking type, the market is segmented into monophasic and biphasic. In 2021, the monophasic segment held the highest market share and is anticipated to expand at the highest CAGR during the forecast period, 2022-2029.

Table of Segmentation